Motley Fool Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Motley Fool Wealth Management's DGX Position: Q2 2020 in Review
Motley Fool Wealth Management sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 4,871 shares — an estimated $391K sold.
Motley Fool Wealth Management first reported a position in DGX in Q1 2017 and held it in 13 quarters. The position peaked at $521K in Q4 2019. 748 funds tracked by Wall St. Rank hold DGX as of Q2 2020.
- Motley Fool Wealth Management reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
- Motley Fool Wealth Management sold 4,871 Quest Diagnostics shares in Q2 2020, an estimated $391K.
- Motley Fool Wealth Management first reported a position in Quest Diagnostics in Q1 2017 and held it in 13 quarters.
- Motley Fool Wealth Management's Quest Diagnostics position peaked at $521K in Q4 2019.
- 748 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.
Based on Motley Fool Wealth Management's 13F filing for Q2 2020, filed 12 Aug 2020.